Sjogrens Syndrome Therapeutics Market by Application, Type, and Geography Forecast and Analysis 2023-2027

Published: Sep 2023

Pages: 156

SKU: IRTNTR70328

Snapshot

Sjogren Syndrome Therapeutics Market 2023-2027

The global sjogrens syndrome therapeutics market size is estimated to grow by USD 691.09 million at a CAGR of 6.53% between 2022 and 2027.

The global sjogrens syndrome therapeutics market is a niche market. Though the main cause of Sjogren's syndrome is unknown, scientists believe that it is mostly caused due to autoimmune diseases such as rheumatoid arthritis and lupus. In order to treat the disease, there are several medicines available. With the strong pipeline and rising awareness about the syndrome, some drugs are likely to be approved through various initiatives and programs undertaken by companies during the forecast period. The aim is to obtain the patient's opinion so that approval can be obtained. To ensure that patients' perspectives were included in the trial design, the diversity and patient engagement team established Sjogren's Patient Engagement Network (PEN).

Technavio has segmented the market into Application, Type, and Geography

The application is classified into clinical and hospital
The type is classified into primary and secondary
The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the size of the Sjogrens Syndrome Therapeutics Market During the Forecast Period?

To learn more about this report, Request Free Sample

Sjogren Syndrome Therapeutics Market Segmentation by Application, Type, and Geography Analysis

Application Analysis

Clinical

The market share growth by the clinical segment will be significant during the forecast period. Market segmentation, also known as application segmentation, is a method of identifying different customer segments with unique needs and preferences in the context of a larger market. In the context of the global market for sjogrens syndrome therapeutics, this segmentation allows for product and service adjustments based on the specific clinical application needs of pharmaceutical companies and healthcare providers.

Get a glance at the market contribution of various segments View a PDF Sample

The clinical segment was valued at USD 991.80 million in 2017. Clinical therapeutics are also available to address the muscular-skeletal manifestations of sjogrens syndrome. This autoimmune condition can have a wide range of effects on tissues and structures, such as joints, muscles, and connective tissue, resulting in symptoms such as joint pain, muscle stiffness, and arthritis. Therefore, it is essential to provide tailored treatments for the improvement of mobility, comfort, and optimal functioning in response to these symptoms. These mentioned clinical uses will expand the growth of the global Sjorgens syndrome therapeutics market during the forecast period.

Type Analysis

Primary Sjogrens

The primary sjogrens syndrome segment is a major segment of the global Sjogrens therapeutics market. Primary sjogrens syndrome is a systematic autoimmune disorder of the exocrine glands. The common symptoms include dryness in the mouth and eyes. Primary sjogrens syndrome is more prevalent among women than men. Women also experience dryness in the vagina. The symptoms are known as sicca symptoms, including xerophthalmia (dry eyes) and xerostomia (dry mouth). Although there are treatments available in the market for sicca symptoms, there is currently no cure for the condition. All these symptoms lead to a higher demand for Sjorgens syndrome therapeutics and thereby increase the growth of the market in focus.

Secondary Sjogrens

Secondary sjogrens syndrome is associated with other autoimmune disorders, such as systemic lupus erythematosus, rheumatoid arthritis, and connective tissue diseases. Its symptoms are mainly the same as primary Sjogren's syndrome, known as sicca symptom. sjogrens syndrome is the second-most common rheumatic autoimmune disorder after RA and SLE. The market has witnessed the development of symptomatic treatments in clinical trials, which will drive the market in focus growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The growing incidence of autoimmune disorders drives the sjogrens syndrome therapeutics market in North America due to changing lifestyles such as taking a low-fat diet. According to the Centers for Disease Control and Prevention (CDC), autoimmune diseases are the third most common category in the US. It is also known that the majority of trials in developing treatment for Sjogren's Syndrome are carried out in Northern America. This will drive the growth of the sjogrens syndrome therapeutics market in North America. During the forecast period, upcoming approvals of therapeutic candidates by the US FDA (Food and Drug Administration)will drive market growth in the region.

COVID Recovery Analysis

The coronavirus pandemic of 2020 had a major influence on the North American sjogrens syndrome therapeutics market. The pandemic has resulted in restrictions, lockdowns, and reduced production capacity from March 2020, which is delaying the availability of Sjogren's syndrome medicines due to shortages in supply. Furthermore, patients have encountered difficulties in obtaining the necessary medications, resulting in heightened anxieties and a decrease in overall market demand.

Buy Now Full Report and Discover More

Key Sjogrens Syndrome Therapeutics Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

ADVANZ PHARMA Corp. - The company offers sjogrens syndrome therapeutics such as a broad range of therapeutic areas, including hepatology, gastroenterology, anti-infectives, critical care, and endocrinology.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Sjogrens Syndrome Therapeutics Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.

Key Sjogrens Syndrome Therapeutics Market Drivers

The high prevalence and incidence of Sjogren's syndrome is driving growth in the sjogrens syndrome therapeutics market. Sjogren's Syndrome is a condition that can be associated with other immune disorders, for example, rheumatoid arthritis and lupus. The condition is more common in women than men. The incidence of sjogrens syndrome is rising globally. sjogrens syndrome is not fatal.

However, if it is left untreated, people can develop lymphoma, which can result in dental cavities, yeast infections, and vision problems. Due to changes in lifestyle and dietary habits, the prevalence of this disease is increasing. The prevalence of sjogrens syndrome depends on SLE. The high prevalence of sjogrens syndrome is expected to boost the market growth during the forecast period.

Significant Sjogrens Syndrome Therapeutics Market Trends

The rising number of awareness programs is a key trend in the sjogrens syndrome therapeutics market. The Sjogren's Syndrome is currently the most common disease in the world. Dry mouth is not a trivial symptom for sjogrens syndrome patients as it has a considerable impact on their daily lives. Dry eye is one of the most common early symptoms of the disease.

There is an increase in efforts to educate eye care providers to identify and be aware of disease symptoms. When patients talk to their doctors about potential medical diagnostics and treatments, they also need to be informed and ready for action. Many organizations are focusing on increasing the awareness of sjogrens syndrome. Awareness programs will drive the global sjogrens syndrome therapeutics market during the forecast period.

Major Sjogrens Syndrome Therapeutics Market Challenges

The unwanted immunogenicity of therapeutic antigens is a major challenge in the sjogrens syndrome therapeutics market. Undesirable immunogenicity occurs when the body's immune system responds to a therapeutic antigen. This reaction leads to the production of anti-drug antibodies (ADAs) that inactivate the therapeutic effects of the treatment. In rare cases, they can induce adverse effects. Immunogenicity is a major factor that can limit the use of therapeutics, which may hinder market growth. Immunosuppression, which may lead to opportunistic infections, is caused by the use of biologics.

Moreover, in order to treat rheumatoid arthritis, there is an increase in the introduction and use of biotherapeutics. The formation of immune complexes between ADAs and biologics may result in clearance, reduce serum biologic levels, and may have a more direct neutralizing effect on product-target binding. Such adverse effects can result in low patient compliance. This is eventually expected to hinder the growth of the global sjogrens syndrome therapeutics market during the forecast period.

Buy Now Full Report and Discover More

Key Sjogrens SyndromeTherapeutics Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Sjogrens Syndrome Therapeutics Market Customer Landscape

Segment Overview

The sjogrens syndrome therapeutics market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Application Outlook (USD Million, 2017 - 2027)
- Clinical
- Hospital

Type Outlook (USD Million, 2017 - 2027)
- Primary
- Secondary

Region Outlook (USD Million, 2017 - 2027)
- North America
  - The U.S.
  - Canada
- Europe
  - U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- ROW
  - Argentina
  - Brazil
  - Rest of the World

Sjogrens Syndrome Therapeutics Market Scope
Report Coverage	Details
Page number	156
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 6.53%
Market growth 2023-2027	USD 691.09 million
Market structure	Fragmented
YoY growth 2022-2023(%)	5.51
Regional analysis	North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution	North America at 39%
Key countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	AbbVie Inc., ADVANZ PHARMA Corp., Biogen Inc., Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc, Johnson and Johnson, MorphoSys AG, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., RemeGen Ltd., Resolve Therapeutics LLC, Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and TearSolutions Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Sjogrens Syndrome Therapeutics Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the sjogrens syndrome therapeutics between 2023 and 2027
Precise estimation of the size of the sjogrens syndrome therapeutics market size and its contribution to the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies' position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
Thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of sjogrens syndrome therapeutics market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global sjogrens syndrome therapeutics market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on global sjogrens syndrome therapeutics market 2017 - 2021 ($ million)

4.2 Application Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)

4.3 Type Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Application - Market share 2022-2027 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Clinical - Market size and forecast 2022-2027
- Exhibit 34: Chart on Clinical - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Clinical - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Clinical - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Clinical - Year-over-year growth 2022-2027 (%)

6.4 Hospital - Market size and forecast 2022-2027
- Exhibit 38: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Hospital - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Hospital - Year-over-year growth 2022-2027 (%)

6.5 Market opportunity by Application
- Exhibit 42: Market opportunity by Application ($ million)
- Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type

7.1 Market segments
- Exhibit 44: Chart on Type - Market share 2022-2027 (%)
- Exhibit 45: Data Table on Type - Market share 2022-2027 (%)

7.2 Comparison by Type
- Exhibit 46: Chart on Comparison by Type
- Exhibit 47: Data Table on Comparison by Type

7.3 Primary - Market size and forecast 2022-2027
- Exhibit 48: Chart on Primary - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Primary - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Primary - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Primary - Year-over-year growth 2022-2027 (%)

7.4 Secondary - Market size and forecast 2022-2027
- Exhibit 52: Chart on Secondary - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Secondary - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Secondary - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Secondary - Year-over-year growth 2022-2027 (%)

7.5 Market opportunity by Type
- Exhibit 56: Market opportunity by Type ($ million)
- Exhibit 57: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2022-2027 (%)
- Exhibit 60: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Germany - Market size and forecast 2022-2027
- Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.9 China - Market size and forecast 2022-2027
- Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)

9.10 Japan - Market size and forecast 2022-2027
- Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)

9.11 UK - Market size and forecast 2022-2027
- Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption

11.4 Industry risks
- Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 105: Vendors covered

12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification

12.3 ADVANZ PHARMA Corp.
- Exhibit 107: ADVANZ PHARMA Corp. - Overview
- Exhibit 108: ADVANZ PHARMA Corp. - Business segments
- Exhibit 109: ADVANZ PHARMA Corp. - Key offerings
- Exhibit 110: ADVANZ PHARMA Corp. - Segment focus

12.4 Bristol Myers Squibb Co.
- Exhibit 111: Bristol Myers Squibb Co. - Overview
- Exhibit 112: Bristol Myers Squibb Co. - Product / Service
- Exhibit 113: Bristol Myers Squibb Co. - Key news
- Exhibit 114: Bristol Myers Squibb Co. - Key offerings

12.5 Daiichi Sankyo Co. Ltd.
- Exhibit 115: Daiichi Sankyo Co. Ltd. - Overview
- Exhibit 116: Daiichi Sankyo Co. Ltd. - Product / Service
- Exhibit 117: Daiichi Sankyo Co. Ltd. - Key news
- Exhibit 118: Daiichi Sankyo Co. Ltd. - Key offerings

12.6 GlaxoSmithKline Plc
- Exhibit 119: GlaxoSmithKline Plc - Overview
- Exhibit 120: GlaxoSmithKline Plc - Business segments
- Exhibit 121: GlaxoSmithKline Plc - Key news
- Exhibit 122: GlaxoSmithKline Plc - Key offerings
- Exhibit 123: GlaxoSmithKline Plc - Segment focus

12.7 Hikma Pharmaceuticals Plc
- Exhibit 124: Hikma Pharmaceuticals Plc - Overview
- Exhibit 125: Hikma Pharmaceuticals Plc - Business segments
- Exhibit 126: Hikma Pharmaceuticals Plc - Key offerings
- Exhibit 127: Hikma Pharmaceuticals Plc - Segment focus

12.8 Horizon Therapeutics Plc
- Exhibit 128: Horizon Therapeutics Plc - Overview
- Exhibit 129: Horizon Therapeutics Plc - Business segments
- Exhibit 130: Horizon Therapeutics Plc - Key news
- Exhibit 131: Horizon Therapeutics Plc - Key offerings
- Exhibit 132: Horizon Therapeutics Plc - Segment focus

12.9 Johnson and Johnson
- Exhibit 133: Johnson and Johnson - Overview
- Exhibit 134: Johnson and Johnson - Business segments
- Exhibit 135: Johnson and Johnson - Key news
- Exhibit 136: Johnson and Johnson - Key offerings
- Exhibit 137: Johnson and Johnson - Segment focus

12.10 MorphoSys AG
- Exhibit 138: MorphoSys AG - Overview
- Exhibit 139: MorphoSys AG - Product / Service
- Exhibit 140: MorphoSys AG - Key offerings

12.11 Novartis AG
- Exhibit 141: Novartis AG - Overview
- Exhibit 142: Novartis AG - Business segments
- Exhibit 143: Novartis AG - Key offerings
- Exhibit 144: Novartis AG - Segment focus

12.12 Otsuka Holdings Co. Ltd.
- Exhibit 145: Otsuka Holdings Co. Ltd. - Overview
- Exhibit 146: Otsuka Holdings Co. Ltd. - Business segments
- Exhibit 147: Otsuka Holdings Co. Ltd. - Key offerings
- Exhibit 148: Otsuka Holdings Co. Ltd. - Segment focus

12.13 RemeGen Ltd.
- Exhibit 149: RemeGen Ltd. - Overview
- Exhibit 150: RemeGen Ltd. - Product / Service
- Exhibit 151: RemeGen Ltd. - Key offerings

12.14 Resolve Therapeutics LLC
- Exhibit 152: Resolve Therapeutics LLC - Overview
- Exhibit 153: Resolve Therapeutics LLC - Product / Service
- Exhibit 154: Resolve Therapeutics LLC - Key offerings

12.15 TearSolutions Inc.
- Exhibit 155: TearSolutions Inc. - Overview
- Exhibit 156: TearSolutions Inc. - Product / Service
- Exhibit 157: TearSolutions Inc. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 158: Inclusions checklist
- Exhibit 159: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 160: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 161: Research methodology
- Exhibit 162: Validation techniques employed for market sizing
- Exhibit 163: Information sources

13.5 List of abbreviations
- Exhibit 164: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

sjogrens syndrome therapeutics market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis